Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Cyclopentanohydrophenanthrene ring system doai
Patent
1986-10-14
1989-03-14
Robinson, Douglas W.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Cyclopentanohydrophenanthrene ring system doai
514913, 514974, A61K 31595
Patent
active
048124486
ABSTRACT:
A novel pharmacologic therapy for treatment of idiopathic primary open angle glaucoma, drug-induced glaucoma and elevated intraocular pressure is disclosed. The pharmacologic therapy consists of a novel composition comprised of 17-alpha-methyl-testosterone and a physiologically tolerable carrier. In accordance with a method aspect of this invention, the active ingredient is administered to the eye of a warm blooded animal in such a manner as to maintain physiologic or normal intraocular pressure, or to return elevated intraocular pressure to normal levels. The method aspect of this invention may also be employed to ameliorate drug induced elevated intraocular pressure.
REFERENCES:
"Steroids"--Fieser et al., p. 519-1959.
Modern Drug Encyclopedia (1975), pp. 577, 578, 579 & 780.
Lamble, J. W. and Lamble, A. P., "Some Effects of Progestogens, Oestrogens and Androgens on the Ocular Tension of Rabbits and Owl Monkeys"; Exp. Eye Res., vol. 26, pp. 599-610 (1978).
Armaly, M. F., M.D.; "Effect of Corticosteroids on Intraocular Pressure and Fluid Dynamics", Archiv. of Ophthalmol., vol. 70, pp. 492-497 (1963).
Dorsch, M.D., William and Thygeson, M.D., Phillip; "The Clinical Efficacy of Medrysone, a New Ophthalmic Steroid", Amer. Jour. Ophthalmol., vol. 65, No. 1, pp. 74, 75 (1968).
Godel, Regenbogen and Stein; "On the Mechanism of Cortico Steroid Induced Ocular Hypertension"; Annals of Ophthal., pp. 191-196 (1978).
Treister and Mannor, "Intraocular Pressure and Outflow Facility Effect of Estrogen and Combined Estrogen-Progestin Treatment in Normal Human Eyes": Arch. Ophthal., vol. 83, pp. 311-318 (1970).
Meyer, Roberts, Liebowitz, McGowan and Honle; "Influence of Norethynodrel with Mestranol on Intraocular Pressure in Glaucoma"; Arch. Ophthal., vol. 75, pp. 771-773 (1966).
Meyer, Leibowitz, Christman, Niffenegger; "Influence of Norethynodrel with Mestranol on Intraocular Pressure in Glaucoma"; Arch. Ophthal., vol. 75, pp. 157-161 (1966).
Cantrill, Palmberg, Fink, Waltman, Podos and Becker; "Comparison of an In Vitro Potency of Corticosteroids with Ability to Raise Intraocular Pressure"; Amer. Jour. Opthal., vol. 79, No. 6, p. 1012 (1975).
LandOfFree
Method for the prevention of ocular hypertension, treatment of g does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Method for the prevention of ocular hypertension, treatment of g, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Method for the prevention of ocular hypertension, treatment of g will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-893873